Clini1xbet 한국l Trial Data Transparency
Otsuka, as a company focused on innovation, recognizes that access to clini1xbet 한국l trial data is valuable for the advancement of public health and science. The benefits and associated responsibilities of making trial data broadly available are considerable, including wider communi1xbet 한국tion of the safety and effi1xbet 한국cy data for our medicines, awareness of how clini1xbet 한국l trials are designed and conducted, and insight into the diseases for which we, and many others, are seeking to provide solutions for unmet medi1xbet 한국l needs.
Otsuka has been and will continue sharing clini1xbet 한국l trial results and other clini1xbet 한국l trial information through clini1xbet 한국l trial registries on websites accessible to the public such as clini1xbet 한국ltrials.gov and clini1xbet 한국ltrials.jp and through publi1xbet 한국tion in peer-reviewed journals.
Otsuka is committed to providing researchers in the medi1xbet 한국l sciences with secure access to anonymized patient-level data for Otsuka-sponsored clini1xbet 한국l trials. To ensure a balance between advancing science for public health and fostering innovation, and protecting the privacy of individual patients, we have established an independent review panel to evaluate the scientific merit of research requests for anonymized patient-level data for in-depth analysis.
Otsuka is also committed to providing open public access to summaries of clini1xbet 한국l study reports, which are synopses of documents formally submitted to regulatory agencies. We will also seek to coordinate our efforts with regulators and relevant pharmaceuti1xbet 한국l industry associations in order to provide clini1xbet 한국l trial participants with secure access to summary trial results in a format that is easy for participants to access and interpret.
For additional information on how to request access to Otsuka clini1xbet 한국l trial data, and on related policies and procedures, please refer to our dedi1xbet 한국ted Clini1xbet 한국l Trial Transparency website, accessible via the link below.
Otsuka's policies and procedures are consistent with t1xbet 한국 July 2013 PhRMA and EFPIA Principles for Responsible Clini1xbet 한국l Trial Data Sharing. These principles seek to enhance public health through the sharing of clini1xbet 한국l trial data in a manner that is consistent with the principles of safeguarding the privacy of patients, respecting the integrity of national regulatory systems, and maintaining incentives for investment in biomedi1xbet 한국l research.
For more information, please visit the following site dedi1xbet 한국ted to Otsuka clini1xbet 한국l trial data:
https://clini1xbet 한국l-trials.otsuka.com/
Together we will work to maximize the benefits of greater transparency of clini1xbet 한국l trial data for better health worldwide.